Golden rules for registrars
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
The report, entitled Getting it right for people with cancer: the clinical case for change, highlights many successes including decreasing mortality rates and an increase in the number of specialists. However, to meet greater future demand Professor Richards says that the DoH needs to push ahead with reforming the way cancer services are provided in the NHS.
Professor Richards suggests that improvements can be implemented through, better co-ordination of patient care, centralisation of complex services, moving simpler tests and treatments closer to the patients and ensuring greater staff flexibility.
'Cancer care has improved greatly since I first qualified in the 1970s,' says Professor Richards.
'It is important that we press on with these changes as cancer will become ever more common as more people live longer.'
MIMS links
Cancer
What do you think? Comment below or email us at healthcare.republic@haymarket.com.
Quick search - use * for an abbreviated search, eg nico*
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more
Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more
Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more
Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more
Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more
Comments
Only registered users may comment. Log in now or register for a free account.